← Back to Patent Explorer
US4378353A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel C-076 compounds

Assignee: Merck and Co Inc
•
Filing: 1981-02-17
•
Granted: 1983-03-29
•
Expires: 2001-02-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are disclosed certain new compounds related to C-076 compounds which have been produced by a mutant of the culture that produced the original C-076 compounds and isolated from the fermentation broth thereof. The compounds retain the C-076 16-membered cyclic backbone, however, the groups attached thereto are considerably modified from the original C-076 compounds. The new compounds have been found to retain the biological activity of the parent C-076 compounds. The compounds are thus potent antiparasitic agents and compositions and methods for such uses are also disclosed.

Inventors

  • 👤 Robert T. Goegelman
  • 👤 Vincent P. Gullo
  • 👤 Louis Kaplan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 03:45
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/12; C07D493/20; A; A61; A61P; A61P31/00; A61P31/04; C07H; C07H19/00; C07H19/01; C12; C12N; C12N1/00; C12N1/20; C12N1/205; C12P; C12P17/00; C12P17/18; C12P17/181; C12P19/00; C12P19/44; C12P19/60; C12P19/62; C12P19/623; C12R; C12R2001/00; C12R2001/01; C12R2001/465

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 50 words
A compound having the formula ##STR5## wherein: (a.) R 1 is α-L-oleandrosyl; R 2 is sec-butyl; and R 3 is methyl; (b.) R 1 is α-L-oleandrosyl; R 2 is sec-butyl; and R 3 is hydrogen; and (c.) R 1 is α-L-oleandrosyl-α-L-oleandrosyl; R 2 is sec-butyl and R 3 is hydrogen.
Claim 2
Dependent Claim 50 words
A compound having the formula ##STR5## wherein: (a.) R 1 is α-L-oleandrosyl; R 2 is sec-butyl; and R 3 is methyl; (b.) R 1 is α-L-oleandrosyl; R 2 is sec-butyl; and R 3 is hydrogen; and (c.) R 1 is α-L-oleandrosyl-α-L-oleandrosyl; R 2 is sec-butyl and R 3 is hydrogen.
Claim 3
Dependent Claim 19 words
The compound of claim 1 wherein R 1 is α-L-oleandrosyl; R 2 is sec-butyl; and R 3 is methyl.
Claim 4
Dependent Claim 19 words
The compound of claim 1 wherein R 1 is α-L-oleandrosyl; R 2 is sec-butyl; and R 3 is hydrogen.
Claim 5
Dependent Claim 19 words
The compound of claim 1 wherein R 1 is α-L-oleandrosyl-α-L-oleandrosyl; R 2 is sec-butyl and R 3 is hydrogen.
Claim 6
Dependent Claim 38 words
A compound having the formula: ##STR6## wherein: (a.) R 2 is isopropyl; and R 3 is methoxy; (b.) R 2 is sec-butyl; and R 3 is keto; and (c.) R 2 is iso-propyl; and R 3 is keto.
Claim 7
Dependent Claim 38 words
A compound having the formula: ##STR6## wherein: (a.) R 2 is isopropyl; and R 3 is methoxy; (b.) R 2 is sec-butyl; and R 3 is keto; and (c.) R 2 is iso-propyl; and R 3 is keto.
Claim 8
Dependent Claim 15 words
The compound of claim 5 wherein R 2 is iso-propyl; and R 3 is methoxy.
Claim 9
Dependent Claim 15 words
The compound of claim 5 wherein R 2 is sec-butyl; and R 3 is keto.
Claim 10
Dependent Claim 15 words
The compound of claim 5 wherein R 2 is iso-propyl and R 3 is keto.
Claim 11
Dependent Claim 20 words
A compound having the formula: ##STR7## wherein R 1 is α-L-oleandrosyl-α-L-oleandrosyl; R 2 is sec-butyl; and R 3 is hydrogen.
Claim 12
Dependent Claim 20 words
A compound having the formula: ##STR7## wherein R 1 is α-L-oleandrosyl-α-L-oleandrosyl; R 2 is sec-butyl; and R 3 is hydrogen.
Claim 13
Independent Claim 31 words
A method for the treatment of parasite infections in animals infected with parasites, which comprises administering to said animal an effective amount of a compound of claims 1, 5 or 9.
Claim 14
Dependent Claim 27 words
A composition useful for the treatment of parasite infections which comprises an inert carrier and an effective amount of a compound of claims 1, 5 or 9.

References Cited (Backward Citations)

US3950360A Cited
US3984564A Cited
GB1573955A Cited
US4134973A Cited
US4285963A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-03-28 1986-09-27 1987-03-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-03-28 1990-09-27 1991-03-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-03-28 1994-09-27 1995-03-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag